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Geographical variation in breast cancer survival rates for women
diagnosed in England between 1992 and 1994
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The 5-year relative survival rates of women diagnosed with breast cancer between 1992 and 1994 were compared among the 99
Health Authorities (1999 boundaries) of England. Substantial variation, with evidence of geographical clustering was observed. Part of
this variation was explained by differences in deprivation between Health Authorities, in particular by the percentage of class IV and V
households.
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The chances of surviving a given cancer are not the same for all
patients in all regions of England (Yuen et al, 1997; Coleman et al,
1999). Regional differences in survival within the UK have also
been reported for several cancers (Silman and Evans, 1981;
Chouillet, Bell and Hiscox, 1994; Macleod et al, 1998). In
particular, there is evidence that, for most adult cancers, patients
from affluent neighbourhoods have better survival than patients
from deprived neighbourhoods. Such differentials are most
unlikely to be attributable to chance (Kogevinas, 1990; Kogevinas
et al, 1991; Schrijvers, 1996; Kidd, 1997; Pollock and Vickers, 1997)
or to the extent of disease at the time of diagnosis (Carnon et al,
1994; Schrijvers et al, 1995a, b). For breast cancer patients, these
differentials have been associated with variations in diagnostic
investigations both in England and Wales and in Scotland, and
with departures from treatment guidelines (Gillis and Hole, 1996;
Richards et al, 1996; Twelves et al, 1998; Stockton, 2002). Using
detailed geographical survival data on breast cancer patients
diagnosed in England in 1992–1994, we have compared survival
patterns across regions and investigated their variation using
demographic and socioeconomic indicators.
PARTICIPANTS AND METHODS
Participants
Incidence data for breast cancer in 1992–1994, submitted to the
Office for National Statistics by the nine regional cancer registries
in England, were linked to death and emigration data by the
National Health Service Central Register (NHSCR). Data were
frozen in October 2000, when follow-up was considered acceptable
up to 31 December 1999 (Coleman et al, 2000). A total of 93 687
records were included in the analysis. Some (5368) records were
declared ineligible as the tumour was either in situ, benign or
metastatic, or data were incomplete. Of the 88 319 eligible records,
11% were later excluded from the analysis, mainly for one of three
reasons: survival time could not be calculated because only the
date of death was known (death certificate only, 5341), a previous
primary malignancy (1860), or synchronous tumours (872), or for
lack of reliable information from NHSCR about vital status when
the data were frozen (812). Details of these and other criteria,
which accounted for the remaining 530 exclusions, have been
published (Coleman et al, 1999). After exclusions, a total of 78 904
breast cancer patients, with age at diagnosis ranging from 16 to 99
years, were available for analysis.
Statistical analysis
The 5-year relative survival rates were computed separately for
each of the 99 Health Authorities (HAs) in England (1999
boundaries). We used the age- and sex-specific England and
Wales life-tables for the 1990–1992 pericensal period and adapted
a method to estimate relative survival rates (Esteve et al, 1990).
The relative survival rates were plotted using a Geographical
Information Systems (GIS) map. To investigate their variation
across the nine English regions, several potential covariates were
considered, in line with other studies (Quinn and Allen, 1995;
Schrijvers et al, 1995; Coleman et al, 1999). These were all defined
at the HA level and referred to either summary statistics of patient
characteristics (e.g. mean age at diagnosis for each HA) or to
summary statistics of enumeration district (ED) characteristics
derived from the 1991 Census (e.g. mean percentage of Asians for
every HA). They are listed in Table 1.
In descriptive analyses, all variables were grouped into
categories defined by the tertiles of their distribution, but in
regression models they were left as continuous variables, centred
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on their means (by subtracting the mean value from each
observation) to obtain interpretable baseline rates. Fixed and
random effects linear regression models (as used in meta-analyses,
Whitehead and Whitehead, 1991) were fitted to quantify the
variation in HA-specific relative survival rates and to identify the
strongest HA-level covariates. Robust estimates of precision were
used with fixed effects models in order to deal with the likely
geographical correlation among the individual HAs. By contrast,
random effects models directly specify such correlations leading to
estimates of between-HA variances (t2). These are measures of the
heterogeneity among HAs that is unaccounted for by the covariates
included in a model. Tests of significance and departure from
linearity of continuous effects were performed via likelihood ratio
tests (Clayton and Hills, 1993). Multivariable fixed effects models
were compared using the strategy recommended by Collett (1994:
pp 78–85), with Po0.10 as the inclusion criterion. The potential
confounding effect of mean age at diagnosis was examined by
forcing it into the final model.
Analyses were performed in Stata version 8 (StataCorp, 2003).
Geographical Information Systems maps were produced in
Arcview (Arcview GIS. v3.1; Environmental Systems Research
Institute Inc., ).
RESULTS
Of the 78 904 women included, 27 532 (35%) died within 5 years of
diagnosis. The mean 5-year relative survival rate was 75%, with the
HA-specific values ranging from 66 to 85%. There was evidence of
some clustering among adjacent HAs, likely to be due to their
sharing of a number of characteristics (Figure 1). Random effects
meta-analysis without covariates provided evidence of a relatively
large and significant between-HA variance (estimated t2¼ 8.47;
Po0.001), thus supporting the visual impression of variability.
Table 1 Summary statistics of the Health Authority (HA)-specific 5-year
relative survival rates for women diagnosed with breast cancer in 1992–
1994 by categories of potential explanatory variables
5-Year relative survival
Variables Median
Interquartile
range
Geographic
Region
London 77.44 75.63, 79.58
Eastern 78.04 76.92, 78.91
North West 74.03 72.12, 75.09
Northern and Yorkshire 74.38 71.92, 75.01
South East 75.95 73.94, 77.63
South West 74.53 72.72, 74.87
Trent 72.41 69.72, 74.35
West Midlands 75.39 74.08, 76.87
Demographic (grouped in thirds)
Mean age at diagnosis of breast cancer cases in HA
Low (58.8– ) 75.76 73.76, 77.87
Medium (61.4– ) 74.82 73.50, 78.21
High (62.3–66.6) 74.50 72.38, 75.51
Mean percentage of women aged 15–64 years
among EDs in HAa
Low (59.0– ) 74.56 71.92, 75.39
Medium (63.1– ) 74.47 72.38, 76.46
High (64.4–71.0) 76.70 74.70, 78.41
Mean percentage of Black Afro Caribbean among EDs
in HAa
Low (0.05– ) 74.47 72.63, 76.44
Medium (0.28– ) 74.87 73.96, 76.87
High (0.87–18.1) 75.76 72.83, 77.87
Mean percentage of Asians among EDs in HAa
Low (0.06– ) 74.56 72.76, 76.44
Medium (0.48– ) 74.71 73.40, 77.88
High (2.25–18.7) 75.57 72.83, 77.69
Socioeconomic (grouped in thirds)
Mean percentage of social class IV or V heads of
household among EDs in HAa
Low (9.3– ) 76.70 75.51, 78.88
Medium (16.4– ) 74.98 73.96, 77.19
High (19.7–26.9) 72.41 69.72, 74.47
Mean percentage of unemployed among EDs in HAa
Low (4.7– ) 75.98 74.42, 77.91
Medium (6.9– ) 75.33 72.71, 77.69
High (10.2–23.2) 73.76 71.85, 75.39
Carstairs indexa,b
Affluent (2.6– ) 76.52 74.71, 78.17
Medium (0.2– ) 74.82 73.18, 77.19
Deprived (1.8–10.4) 73.37 71.39, 75.51
Mean HA Townsend score among EDs in HAa
Affluent (5.5– ) 76.66 74.71, 78.17
Medium (2.4– ) 74.55 72.76, 76.05
Deprived (1.0–12.2) 74.30 71.85, 76.40
Mean HA Jarman index among EDs in HAa
Affluent (27.7– ) 76.44 74.57, 77.97
Medium (9.0– ) 74.49 72.71, 76.69
Deprived (4.5–61.4) 74.56 71.85, 76.40
aVariable derived from 1991 Census data on ED characteristics. bWeighted mean of
ED values.
5-Year relative survival (quartiles)
66.16 −
72.83 −
74.87 −
77.21 − 85.31
Figure 1 Observed geographical variation in 5-year relative survival rates
among the 99 England and Wales Health Authorities (1999 boundaries):
categories defined by the quartiles of the distribution.
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The distribution of 5-year relative survival rates by categories of
the available covariates is shown in Table 1. There is evidence of
geographical similarities among the Northern regions, with the
relative survival rates in North West, Trent and Northern and
Yorkshire being on average considerably lower than in London
and in the Eastern and South East regions. Survival rates also
decreased with greater mean age at diagnosis, while it increased
with higher mean proportion of younger (aged 15–64 years)
women living in the HA, the latter possibly being an indicator of
greater affluence. There was some evidence that HAs with a greater
mean percentage of Black Afro-Caribbean and Asians had higher
relative survival rates. Health Authorities with higher mean
proportions of heads of household in lower social classes, or
higher mean unemployment rate, or higher deprivation indices
showed strong negative trends in survival rates.
Univariable fixed effects regression analyses of these same
factors, treated as continuous variables, revealed that the socio-
economic and geographical indicators were the strongest pre-
dictors of the 5-year survival rates (all Po0.01; Table 2). This is
also shown by the largest reduction in estimated t2 corresponding
to the random effects models that included these variables. None of
them showed evidence of departure from the null hypothesis of a
linear effect (with the exception of HA mean percentage of black
Afro-Caribbean; P¼ 0.03). Multivariable fixed effects models
revealed social class and region to be the most important factors
(Table 3). The mean age at diagnosis did not confound or modify
these effects. Repeating the analyses using random effects models
confirmed these results and showed that the between-HA variation
was more than halved from 8.47 (corresponding to the data of
Figure 1) to 3.87. The intercept in the final random effects model
(75.42%, 95% CI, 73.87, 76.96%) represents the estimated 5-year
relative survival rate for women diagnosed in a London HA with
average percentage (i.e. 17.9%) of class IV and V households. The
estimated coefficient (0.498, 95% CI 0.697, 0.298) instead
Table 2 Crude effects of potential explanatory variables for the HA 5-year relative survival rates estimated using fixed and random effects regression
models
Univariable fixed effects model Univariable random effects model
Explanatory variable Coefficient 95% CIa P-value Coefficient 95% CI P-value s2
Geographic
Region
London (baseline) 1 — — 1 —
Eastern 1.124 (0.962, 3.121) 0.29 1.045 (1.475, 3.565) 0.416
North West 3.300 (5.620,0.976) 0.006 3.460 (5.663,1.258) 0.002
Northern and Yorkshire 2.695 (5.880, 0.489) 0.10 3.238 (5.541,0.935) 0.006 5.76
South East 0.352 (2.787, 2.084) 0.77 0.514 (2.693, 1.665) 0.644
South West 3.186 (5.684,0.688) 0.01 3.092 (5.624,0.559) 0.017
Trent 4.615 (7.031,2.198) o0.001 4.876 (7.307,2.444) o0.001
West Midlands 1.565 (3.992, 0.862) 0.20 1.745 (4.082, 0.592) 0.143
Demographic
HA mean age at breast cancer diagnosis in 1992–1994 0.433 (0.895, 0.029) 0.06 0.415 (0.926, 0.097) 0.11 8.28
HA mean of ED percentages of women aged 15–64 years 0.360 (0.089, 0.631) 0.01 0.408 (0.073, 0.742) 0.02 7.91
HA mean of ED percentages of Black Afro Caribbean 0.053 (0.174, 0.280) 0.65 0.069 (0.164, 0.303) 0.56 8.55
HA mean of ED percentages of Asians 0.038 (0.128, 0.205) 0.65 0.043 (0.146, 0.234) 0.65 8.57
Socioeconomic
HA mean of ED percentages unemployed 0.372 (0.564,0.180) o0.001 0.392 (0.571,0.212) o0.001 6.64
HA mean of ED percentages of class IV and V households 0.529 (0.704,0.353) o0.001 0.551 (0.705,0.397) o0.001 4.44
HA mean of ED Carstairs indices 0.637 (0.960,0.313) o0.001 0.683 (0.971,0.396) o0.001 6.34
HA Townsend score 0.300 (0.512,0.086) 0.006 0.313 (0.501,0.125) 0.001 7.37
HA Jarman index 0.065 (0.107,0.023) 0.003 0.070 (0.108,0.032) o0.001 7.14
Table 3 Final fixed and random effects regression model with the significant predictors
Multivariable fixed effects model Multivariable random effects model
Explanatory variable Coefficient 95% CIa P-value Crude coefficient 95% CI P-value s2
Intercept 75.43 73.78, 77.07 75.42 73.87, 76.96
Region
London (baseline) 1 1
Eastern 1.691 0.115, 3.497 0.066 1.595 0.646, 3.836 0.163
North West 0.879 3.092, 1.334 0.432 0.903 3.129, 1.323 0.426
Northern andYorkshire 0.166 3.018, 3.351 0.918 0.112 2.513, 2.290 0.927
South East 0.454 2.396, 1.488 0.643 0.476 2.415, 1.462 0.630
South West 2.288 4.496, 0.081 0.042 2.105 4.385, 0.175 0.070
Trent 2.270 4.443, 0.081 0.041 2.205 4.630, 0.220 0.075
West Midlands 0.550 2.007, 3.107 0.670 0.419 1.850, 2.688 0.718
HA mean of ED percentages of class IV and V households 0.493 0.707, 0.280 o0.001 0.498 0.697, 0.298 o0.001
3.87
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represents the decrease in 5-year relative survival rates expected in
any region for every percentage increase in HA mean percentage of
class IV and V households. Similarly, the estimated coefficients for
each region represent the increases (or decreases) in rates relative
to the rate expected in a London HA, holding percentage of class
IV and V households fixed.
DISCUSSION
Our findings show that the significant variation in breast cancer
survival between HAs in England can be partly explained by
socioeconomic differentials between and within regions. Although
the observation of an association between breast cancer survival
and deprivation is well documented (Karjalainen, 1991; Schrijvers
et al, 1995; Coleman et al, 1999), our findings add quantitative
estimates of both accountable and residual variation between HAs.
Our results suffer from several limitations. Firstly, since the
measures for deprivation were aggregated at HA level from smaller
units (EDs), the results rely on the assumption that all the variables
that determine survival rates are uniformly distributed within each
HA. If this assumption were incorrect, the estimated effects would
be biased, most probably towards the null hypothesis of no effect.
This assumption of homogeneous deprivation level within each
HA may be more appropriate when the geographical areas are
small, but less so when the areas are as large as HAs. Secondly,
population figures and socioeconomic indicators were taken from
the 1991 decennial census, and therefore may not be accurate in
portraying characteristics of the HA population throughout the
years covered by this study (1992–1999). More up-to-date
administrative data from official sources are becoming available
at small-area level (e.g. income support recipients, Carstairs, 2000).
Unfortunately, these were not available to us at the time of
analysis.
The analyses were carried out at HA level, but HA areas cannot
be considered as ‘units of performance’ in terms of breast cancer
care. Thus, part of the unexplained geographical variation in
survival rates may be due to differences in health care, such as the
timing and extent of initial investigation, or type and departures
from treatment guidelines (Quinn and Allen, 1995), or to
individual level variables, such as the extent of disease at diagnosis
(e.g. tumour grade and stage). These variables were not available to
us. When more individual and HA-level data become available, our
approach should be replicated to monitor improvements in the
quality of detection and care of breast cancer patients and to
inform local public health interventions.
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